期刊文献+

Alzheimer's disease and gut microbiota 被引量:55

Alzheimer's disease and gut microbiota
原文传递
导出
摘要 Alzheimer's disease(AD) is a most common neurodegenerative disorder, which associates with impaired cognition. Gut microbiota can modulate host brain function and behavior via microbiota-gut-brain axis, including cognitive behavior.Germ-free animals, antibiotics, probiotics intervention and diet can induce alterations of gut microbiota and gut physiology and also host cognitive behavior, increasing or decreasing risks of AD. The increased permeability of intestine and blood-brain barrier induced by gut microbiota disturbance will increase the incidence of neurodegeneration disorders. Gut microbial metabolites and their effects on host neurochemical changes may increase or decrease the risk of AD. Pathogenic microbes infection will also increase the risk of AD, and meanwhile, the onset of AD support the "hygiene hypothesis". All the results suggest that AD may begin in the gut, and is closely related to the imbalance of gut microbiota. Modulation of gut microbiota through personalized diet or beneficial microbiota intervention will probably become a new treatment for AD. Alzheimer's disease (AD) is a most common neurodegenerative disorder, which associates with impaired cognition. Gut microbiota can modulate host brain function and behavior via microbiota-gut-brain axis, including cognitive behavior. Germ-free animals, antibiotics, probiotics intervention and diet can induce alterations of gut microbiota and gut physiology and also host cognitive behavior, increasing or decreasing risks of AD. The increased permeability of intestine and blood-brain barrier induced by gut rnicrobiota disturbance will increase the incidence of neurodegeneration disorders. Gut microbial metabolites and their effects on host neurochemical changes may increase or decrease the risk of AD. Pathogenic microbes infection will also increase the risk of AD, and meanwhile, the onset of AD support the "hygiene hypothesis". All the results suggest that AD may begin in the gut, and is closely related to the imbalance of gut microbiota. Modulation of gut microbiota through personalized diet or beneficial microbiota intervention will probably become a new treatment for AD.
出处 《Science China(Life Sciences)》 SCIE CAS CSCD 2016年第10期1006-1023,共18页 中国科学(生命科学英文版)
基金 supported by NS Bio Japan and NS Bio Guangzhou
关键词 阿尔茨海默病 肠道菌群 神经退行性疾病 微生物代谢产物 阿尔茨海默氏病 病原微生物感染 认知行为 有益微生物 Alzheimer's disease, gut microbiota, leaky gut, leaky brain, diet, infection, hygiene hypothesis
  • 相关文献

参考文献2

二级参考文献62

  • 1Rodrigo R, Cauli O, Gomez-Pinedo U, Agusti A, Hernandez-Rabaza V, Garcia-Verdugo JM, Felipo V. Hyperammonemia induces neuro- inflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology, 2010, 139: 675-684.
  • 2Saul WSWB. Hyperammonemic encephalopathy. Medicine (Abing- don), 2002, 81: 240-249.
  • 3Felipo V, Butterworth RF. Neurobiology of ammonia. Prog Neurobiol, 2002, 67: 259-279.
  • 4Lajtha A, Reith MEA, eds. Handbook of Neurochemistry and Molecular Neurobiology. 3rd ed. New York: Springer, 2008.
  • 5Basile AS, Jones EA. Ammonia and GABA-ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology, 1997, 25: 1303-1305.
  • 6Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, Rodrigo JM, Felipo V. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol, 2009, 43: 272-279.
  • 7Gibertini M, Newton C, Friedman H, Klein TW. Spatial learning impairment in mice infected with legionella pneumophila or administered exogenous interleukin-1β. Brain Behav Immun, 1995, 9: 113-128.
  • 8Wiltfang J, Nolte W, Wei?enborn K, Komhuber J, Rüther E. Psychiatric aspects of portal-systemic encephalopathy. Metab Brain Dis, 1998, 13: 379-389.
  • 9Erecinska M, Pastuszko A, Wilson DF, Nelson D. Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects on amines and amino acids. J Neurochem, 1987, 49: 1258-1265.
  • 10R?ssle M, Luft M, Herz R, Klein B, Lehmann M, Gerok W. Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution. Klin Wochenschr, 1984, 62: 867-875.

共引文献29

同被引文献290

引证文献55

二级引证文献307

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部